CD19 and neoplasm: To evaluate the cytotoxic capacity of CD19.CAR-T cells on BH3 mimetic pre-treated tumor cells, BH3 mimetic highly sensitive and low sensitive tumor cells were cultured with BH3 mimetics for 24 h prior to the addition of CD19.CAR-T cells.